Addiction is survival work, effective in the short run, but cyclical and costly over time. There is a way out.
PHILADELPHIA, PA — Aro Biotherapeutics said it will present interim clinical data next month from its ongoing Phase 1b trial ...
Discover J&J’s pipeline strategy for 2026 as it it projects that its sales for the year will be between $100 billion and $101 ...
Byrdie on MSN
Meet the new class of injectables
Hollywood’s favorite new injectables are peptides and NAD+, but what do these treatments actually do?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results